dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Vico-Romero, Judit |
dc.contributor.author | Campos, Carolina |
dc.contributor.author | Cortese, Maria Francesca |
dc.contributor.author | Colomer-Castell, Sergi |
dc.contributor.author | Gregori Font, Josep |
dc.contributor.author | Garcia-Cehic, Damir |
dc.contributor.author | Riveiro-Barciela, Mar |
dc.contributor.author | Buti Ferret, Maria |
dc.contributor.author | Rando Segura, Ariadna |
dc.contributor.author | Ibañez Lligoña, Marta |
dc.contributor.author | ADOMBI, Caroline Mélanie |
dc.contributor.author | Tabernero, David |
dc.contributor.author | Esteban Mur, Juan Ignacio |
dc.contributor.author | RODRIGUEZ-FRIAS, FRANCISCO |
dc.contributor.author | QUER, JOSEP |
dc.date.accessioned | 2024-01-16T08:18:09Z |
dc.date.available | 2024-01-16T08:18:09Z |
dc.date.issued | 2023-12-06 |
dc.identifier.citation | Colomer-Castell S, Gregori J, Garcia-Cehic D, Riveiro-Barciela M, Buti M, Rando-Segura A, et al. In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments. Int J Mol Sci. 2023 Dec 6;24(24):17185. |
dc.identifier.issn | 1661-6596 |
dc.identifier.uri | https://hdl.handle.net/11351/10867 |
dc.description | Seqüenciació profunda; Mutàgens; Quasiespècie |
dc.description.sponsorship | This study was partially supported by Plan Estratègic de Recerca i Innovació en Salut (PERIS)—Direcció General de Recerca i Innovació en Salut (DGRIS), Catalan Health Ministry, Generalitat de Catalunya; Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business, grant number IDI-20200297, Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe; Projects PI19/00301 and PI22/00258 funded by Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union; and Gilead’s biomedical research project GLD21/00006. S.C.-C has received support from Spanish Ministry of Education, grant FPU21/04150. M.I.-L. received the support of a fellowship from the “la Caixa” Foundation (ID 100010434), whose code is “LCF/BQ/DR23/12000020”. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | International Journal of Molecular Sciences;24(24) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antivírics - Ús terapèutic |
dc.subject | Virus de l'hepatitis E - Aspectes genètics |
dc.subject | Anomalies cromosòmiques |
dc.subject.mesh | Antiviral Agents |
dc.subject.mesh | Hepatitis E virus |
dc.subject.mesh | Quasispecies |
dc.subject.mesh | Mutagens |
dc.title | In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/ijms242417185 |
dc.subject.decs | antivíricos |
dc.subject.decs | virus de la hepatitis E |
dc.subject.decs | cuasiespecies |
dc.subject.decs | mutágenos |
dc.relation.publishversion | https://doi.org/10.3390/ijms242417185 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Colomer-Castell S, Campos C, Quer J] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gregori J, Vico-Romero J] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Garcia-Cehic D] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [Riveiro-Barciela M, Buti M, Esteban JI] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rando-Segura A] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Servei de Microbiologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Ibañez-Lligoña M] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Adombi CM] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Institute of Agropastoral Management, University Peleforo Gon Coulibaly, Korhogo, Côte d’Ivoire. [Cortese MF, Tabernero D, Rodriguez-Frias F] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Servei de Bioquímica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 38139013 |
dc.identifier.wos | 001130796900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PID2021-126447OB-I00 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00301 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F00258 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |